Mark Dagostino, MD
Otolaryngology · New Haven, CTNPI 1144230749
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (46.0%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Inspire Medical Systems, Inc. accounts for 92.3% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $1,927 and has fallen 88.4% since, to $224 in 2025.
Across 15 payments — averaging $321.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$4K
- Aerin Medical Inc.$168
- Intersect ENT, Inc.$139
- Harmony Biosciences LLC$30
- Philips North America LLC$18
- Smith+Nephew$14
Across 3 payments — averaging $1050.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Inspire Medical Systems, Inc.$3K
What the payments were for
- Consulting fees$2,05042%
- Speaking & faculty fees$2505%
- Travel & lodging$3056%
- Food & beverage$2,22246%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 10 | $4,457 |
| Aerin Medical Inc. | 1 | $168 |
| Intersect ENT, Inc. | 1 | $139 |
| Harmony Biosciences LLC | 1 | $30 |
| Philips North America LLC | 1 | $18 |
| Smith+Nephew | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire Upper Airway Stimulation System$4,367
- VIVAER STYLUS$168
- RHINAER STYLUS$168
- PROPEL$139
How this compares
$4,827 in reported general payments places this provider in the 80th percentile of 119 otolaryngology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 130 | $2,941 |
| Fluticasone Propionate | 185 | $2,654 |
| Olopatadine Hcl | 16 | $1,743 |
| Azelastine Hcl | 68 | $1,739 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 17 | $832 |
| Fluocinolone Acetonide Oil | 17 | $584 |
| Mometasone Furoate | 28 | $461 |
| Pantoprazole Sodium | 54 | $420 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 32 | $333 |
| Cephalexin | 29 | $207 |
| Methylprednisolone | 26 | $203 |
| Ciprofloxacin Hcl | 18 | $175 |
| Doxycycline Hyclate | 12 | $135 |
| Mupirocin | 15 | $99 |
| Montelukast Sodium | 26 | $82 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in New Haven
- Sara PaiNew Haven$160K
- Richard ManesNew Haven$67K
- Howard BoeyNew Haven$19K
- Wendell YarbroughNew Haven$6K
- Ken YanagisawaNew Haven$5K
- Clarence SasakiNew Haven$5K
- Eaton ChenNew Haven$4K
- Tiffany ChenNew Haven$3K
- Catherine BrophyNew Haven$3K
- Paul FortgangNew Haven$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.